Still defining optimal primaquine therapy against relapse after 63 years of continuous use

Baird J. Kevin

首页> 外文期刊>Travel medicine and infectious disease >Still defining optimal primaquine therapy against relapse after 63 years of continuous use

【24h】

Still defining optimal primaquine therapy against relapse after 63 years of continuous use

机译：连续使用63年后仍可确定最佳的伯氨喹治疗方案，以防止复发

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Travel medicine and infectious disease》 |2015年第3期|共2页
作者
Baird J. Kevin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Still defining optimal primaquine therapy against relapse after 63 years of continuous use [J] . Baird J. Kevin Travel medicine and infectious disease . 2015,第3期

机译：连续使用63年后仍可确定最佳的伯氨喹治疗方案，以防止复发
2. Efficacy of Alemtuzumab Is Durable Over 6 Years in Patients with Active Relapsing-Remitting Multiple Sclerosis and an Inadequate Response to Prior Therapy in the Absence of Continuous Treatment (CARE-MS II) [J] . Broadley S., Alroughani R., Brassat D., Multiple sclerosis: clinical and laboratory research . 2017,第2期

机译：在没有连续治疗的情况下，患有活性复发的多发性硬化和对前治疗的患者的患者持续6年患者耐久性超过6年的疗效（Care-MS II）
3. Durable Suppression of Disease Activity by Alemtuzumab in the Absence of Continuous Treatment Over 6 Years in Patients with Active Relapsing-Remitting Multiple Sclerosis and an Inadequate Response to Prior Therapy (CARE-MS II) [J] . Macdonell Richard A. L., LaGanke Christopher, De Seze Jerome, Multiple sclerosis: clinical and laboratory research . 2017,第2期

机译：Alemtuzumab持续抑制Alemtuzumab在患有6岁以下患者的患者中缺乏持续治疗的患者，患者有活性复发 - 延髓多发性硬化和对先前治疗的反应不足（Care-MS II）
4. Arsenic Salvage Is Superior to Chemotherapy and Bone Marrow Transplantation for Relapsed Acute promyelocytic Leukemia: Ten Years of Experience from Hong Kong [C] . W.Y. Au, R. Liang, A.K.W. Lie, European Haematology Association . 2002

机译：砷救生优于化疗和骨髓移植复发急性突出细胞细胞白血病：来自香港的十年经验
5. Identifying the Optimal Therapeutic Strategy in the Treatment of Substance Use Disorders: Can Pharmacological Therapies Prevent Relapse in Opioid- and Alcohol-Addicted Patients? [D] . Peterkin, Melissa M. 2020

机译：鉴定治疗物质使用障碍的最佳治疗策略：药理学疗法可以防止阿片类药物和醇上瘾的患者复发吗？
6. Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate [O] . C Ford, AD Goodman, K Johnson, -1

机译：连续长期免疫调节治疗复发性硬化：来自美国前瞻性开放标签的15年分析结果醋酸格拉替雷的研究
7. Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma [O] . Carlos Fernández de Larrea, Mette Staehr, Andrea V. Lopez, 2020

机译：定义最佳的双靶型汽车T细胞疗法方法，同时靶向BCMA和GPRC5D，以防止BCMA逃脱驱动多发性骨髓瘤中的复发
8. Hierarchical Nonlinear Mixed Effect Modeling: Defining Post-radiation Therapy Relapse in Prostate Cancer Patients [R] . Hanlon, A. L. 2004

机译：分层非线性混合效应模型：定义前列腺癌患者的放射治疗后复发

Still defining optimal primaquine therapy against relapse after 63 years of continuous use

著录项

相似文献

相关主题

期刊订阅